ALLR: Pangali Forward P/E Allarity Therapeutics, Inc.

Logo grafis Allarity Therapeutics, Inc. (ALLR)

Allarity Therapeutics (ALLR) is developing synergy between cancer diagnostics and treatment through partnerships with clinics. The forward P/E multiple for the company on GURU.Markets captures the current trend, where the parameter value equals 0.00. However, capital shortages and challenges in test implementation pose threats to the business, although the deployment of robotic biochemical screening in laboratories helps minimize errors and accelerate research.

Rasio rega marang bathi mangsa ngarep: Allarity Therapeutics (ALLR) kanggo 04.07.2022 - 17.11.2026

Ringkesan rincian data analitis Allarity Therapeutics, Inc. (ALLR)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:ALLR allarity.com
Produk mawa merek allarity.com

The full utilization of Allarity Therapeutics (ALLR) biopharmaceutical pipelines for oncology drug development drives the dynamics of the business's forward P/E multiple on the GURU.Markets platform, which currently stands at 0.00. This indicator compares the company's current market value with expected net income, allowing investors to filter out market noise and assess the asset's fundamental value through the ratio of market capitalization to future financial results.